Global Canine Stem Cell Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Canine Stem Cell Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 103

Published Date: 07 Jan 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.

According to our (Global Info Research) latest study, the global Canine Stem Cell Therapy market size was valued at USD 63 million in 2022 and is forecast to a readjusted size of USD 80 million by 2029 with a CAGR of 3.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Market competition is intense. Medivet Biologics LLC, VETSTEM BIOPHARMA and J-ARM, etc. are the leaders of the industry, with about 52% market shares.

North America is the largest consumption region of animal stem cell therapy, with a consumption market share nearly 58%. Japan is the second largest supplier of animal stem cell therapy, enjoying production market share nearly 15%.

This report is a detailed and comprehensive analysis for global Canine Stem Cell Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Canine Stem Cell Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global Canine Stem Cell Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Canine Stem Cell Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Canine Stem Cell Therapy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Canine Stem Cell Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Canine Stem Cell Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include VETSTEM BIOPHARMA, Cell Therapy Sciences, Regeneus, Aratana Therapeutics and Medivet Biologics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Canine Stem Cell Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Allogeneic Stem Cells
Autologous Stem cells

Market segment by Application
Veterinary Hospitals
Veterinary Clinics
Veterinary Research Institutes

Market segment by players, this report covers
VETSTEM BIOPHARMA
Cell Therapy Sciences
Regeneus
Aratana Therapeutics
Medivet Biologics
Okyanos
Vetbiologics
VetMatrix
Magellan Stem Cells
ANIMAL CELL THERAPIES
Stemcellvet

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Canine Stem Cell Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Canine Stem Cell Therapy, with revenue, gross margin and global market share of Canine Stem Cell Therapy from 2018 to 2023.
Chapter 3, the Canine Stem Cell Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Canine Stem Cell Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Canine Stem Cell Therapy.
Chapter 13, to describe Canine Stem Cell Therapy research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Canine Stem Cell Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Canine Stem Cell Therapy by Type
1.3.1 Overview: Global Canine Stem Cell Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Canine Stem Cell Therapy Consumption Value Market Share by Type in 2022
1.3.3 Allogeneic Stem Cells
1.3.4 Autologous Stem cells
1.4 Global Canine Stem Cell Therapy Market by Application
1.4.1 Overview: Global Canine Stem Cell Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Veterinary Hospitals
1.4.3 Veterinary Clinics
1.4.4 Veterinary Research Institutes
1.5 Global Canine Stem Cell Therapy Market Size & Forecast
1.6 Global Canine Stem Cell Therapy Market Size and Forecast by Region
1.6.1 Global Canine Stem Cell Therapy Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Canine Stem Cell Therapy Market Size by Region, (2018-2029)
1.6.3 North America Canine Stem Cell Therapy Market Size and Prospect (2018-2029)
1.6.4 Europe Canine Stem Cell Therapy Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Canine Stem Cell Therapy Market Size and Prospect (2018-2029)
1.6.6 South America Canine Stem Cell Therapy Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Canine Stem Cell Therapy Market Size and Prospect (2018-2029)

2 Company Profiles
2.1 VETSTEM BIOPHARMA
2.1.1 VETSTEM BIOPHARMA Details
2.1.2 VETSTEM BIOPHARMA Major Business
2.1.3 VETSTEM BIOPHARMA Canine Stem Cell Therapy Product and Solutions
2.1.4 VETSTEM BIOPHARMA Canine Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 VETSTEM BIOPHARMA Recent Developments and Future Plans
2.2 Cell Therapy Sciences
2.2.1 Cell Therapy Sciences Details
2.2.2 Cell Therapy Sciences Major Business
2.2.3 Cell Therapy Sciences Canine Stem Cell Therapy Product and Solutions
2.2.4 Cell Therapy Sciences Canine Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Cell Therapy Sciences Recent Developments and Future Plans
2.3 Regeneus
2.3.1 Regeneus Details
2.3.2 Regeneus Major Business
2.3.3 Regeneus Canine Stem Cell Therapy Product and Solutions
2.3.4 Regeneus Canine Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Regeneus Recent Developments and Future Plans
2.4 Aratana Therapeutics
2.4.1 Aratana Therapeutics Details
2.4.2 Aratana Therapeutics Major Business
2.4.3 Aratana Therapeutics Canine Stem Cell Therapy Product and Solutions
2.4.4 Aratana Therapeutics Canine Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Aratana Therapeutics Recent Developments and Future Plans
2.5 Medivet Biologics
2.5.1 Medivet Biologics Details
2.5.2 Medivet Biologics Major Business
2.5.3 Medivet Biologics Canine Stem Cell Therapy Product and Solutions
2.5.4 Medivet Biologics Canine Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Medivet Biologics Recent Developments and Future Plans
2.6 Okyanos
2.6.1 Okyanos Details
2.6.2 Okyanos Major Business
2.6.3 Okyanos Canine Stem Cell Therapy Product and Solutions
2.6.4 Okyanos Canine Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Okyanos Recent Developments and Future Plans
2.7 Vetbiologics
2.7.1 Vetbiologics Details
2.7.2 Vetbiologics Major Business
2.7.3 Vetbiologics Canine Stem Cell Therapy Product and Solutions
2.7.4 Vetbiologics Canine Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Vetbiologics Recent Developments and Future Plans
2.8 VetMatrix
2.8.1 VetMatrix Details
2.8.2 VetMatrix Major Business
2.8.3 VetMatrix Canine Stem Cell Therapy Product and Solutions
2.8.4 VetMatrix Canine Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 VetMatrix Recent Developments and Future Plans
2.9 Magellan Stem Cells
2.9.1 Magellan Stem Cells Details
2.9.2 Magellan Stem Cells Major Business
2.9.3 Magellan Stem Cells Canine Stem Cell Therapy Product and Solutions
2.9.4 Magellan Stem Cells Canine Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Magellan Stem Cells Recent Developments and Future Plans
2.10 ANIMAL CELL THERAPIES
2.10.1 ANIMAL CELL THERAPIES Details
2.10.2 ANIMAL CELL THERAPIES Major Business
2.10.3 ANIMAL CELL THERAPIES Canine Stem Cell Therapy Product and Solutions
2.10.4 ANIMAL CELL THERAPIES Canine Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 ANIMAL CELL THERAPIES Recent Developments and Future Plans
2.11 Stemcellvet
2.11.1 Stemcellvet Details
2.11.2 Stemcellvet Major Business
2.11.3 Stemcellvet Canine Stem Cell Therapy Product and Solutions
2.11.4 Stemcellvet Canine Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Stemcellvet Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Canine Stem Cell Therapy Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Canine Stem Cell Therapy by Company Revenue
3.2.2 Top 3 Canine Stem Cell Therapy Players Market Share in 2022
3.2.3 Top 6 Canine Stem Cell Therapy Players Market Share in 2022
3.3 Canine Stem Cell Therapy Market: Overall Company Footprint Analysis
3.3.1 Canine Stem Cell Therapy Market: Region Footprint
3.3.2 Canine Stem Cell Therapy Market: Company Product Type Footprint
3.3.3 Canine Stem Cell Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
4.1 Global Canine Stem Cell Therapy Consumption Value and Market Share by Type (2018-2023)
4.2 Global Canine Stem Cell Therapy Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
5.1 Global Canine Stem Cell Therapy Consumption Value Market Share by Application (2018-2023)
5.2 Global Canine Stem Cell Therapy Market Forecast by Application (2024-2029)

6 North America
6.1 North America Canine Stem Cell Therapy Consumption Value by Type (2018-2029)
6.2 North America Canine Stem Cell Therapy Consumption Value by Application (2018-2029)
6.3 North America Canine Stem Cell Therapy Market Size by Country
6.3.1 North America Canine Stem Cell Therapy Consumption Value by Country (2018-2029)
6.3.2 United States Canine Stem Cell Therapy Market Size and Forecast (2018-2029)
6.3.3 Canada Canine Stem Cell Therapy Market Size and Forecast (2018-2029)
6.3.4 Mexico Canine Stem Cell Therapy Market Size and Forecast (2018-2029)

7 Europe
7.1 Europe Canine Stem Cell Therapy Consumption Value by Type (2018-2029)
7.2 Europe Canine Stem Cell Therapy Consumption Value by Application (2018-2029)
7.3 Europe Canine Stem Cell Therapy Market Size by Country
7.3.1 Europe Canine Stem Cell Therapy Consumption Value by Country (2018-2029)
7.3.2 Germany Canine Stem Cell Therapy Market Size and Forecast (2018-2029)
7.3.3 France Canine Stem Cell Therapy Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Canine Stem Cell Therapy Market Size and Forecast (2018-2029)
7.3.5 Russia Canine Stem Cell Therapy Market Size and Forecast (2018-2029)
7.3.6 Italy Canine Stem Cell Therapy Market Size and Forecast (2018-2029)

8 Asia-Pacific
8.1 Asia-Pacific Canine Stem Cell Therapy Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Canine Stem Cell Therapy Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Canine Stem Cell Therapy Market Size by Region
8.3.1 Asia-Pacific Canine Stem Cell Therapy Consumption Value by Region (2018-2029)
8.3.2 China Canine Stem Cell Therapy Market Size and Forecast (2018-2029)
8.3.3 Japan Canine Stem Cell Therapy Market Size and Forecast (2018-2029)
8.3.4 South Korea Canine Stem Cell Therapy Market Size and Forecast (2018-2029)
8.3.5 India Canine Stem Cell Therapy Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Canine Stem Cell Therapy Market Size and Forecast (2018-2029)
8.3.7 Australia Canine Stem Cell Therapy Market Size and Forecast (2018-2029)

9 South America
9.1 South America Canine Stem Cell Therapy Consumption Value by Type (2018-2029)
9.2 South America Canine Stem Cell Therapy Consumption Value by Application (2018-2029)
9.3 South America Canine Stem Cell Therapy Market Size by Country
9.3.1 South America Canine Stem Cell Therapy Consumption Value by Country (2018-2029)
9.3.2 Brazil Canine Stem Cell Therapy Market Size and Forecast (2018-2029)
9.3.3 Argentina Canine Stem Cell Therapy Market Size and Forecast (2018-2029)

10 Middle East & Africa
10.1 Middle East & Africa Canine Stem Cell Therapy Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Canine Stem Cell Therapy Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Canine Stem Cell Therapy Market Size by Country
10.3.1 Middle East & Africa Canine Stem Cell Therapy Consumption Value by Country (2018-2029)
10.3.2 Turkey Canine Stem Cell Therapy Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Canine Stem Cell Therapy Market Size and Forecast (2018-2029)
10.3.4 UAE Canine Stem Cell Therapy Market Size and Forecast (2018-2029)

11 Market Dynamics
11.1 Canine Stem Cell Therapy Market Drivers
11.2 Canine Stem Cell Therapy Market Restraints
11.3 Canine Stem Cell Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
12.1 Canine Stem Cell Therapy Industry Chain
12.2 Canine Stem Cell Therapy Upstream Analysis
12.3 Canine Stem Cell Therapy Midstream Analysis
12.4 Canine Stem Cell Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Canine Stem Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Canine Stem Cell Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Canine Stem Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Canine Stem Cell Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 5. VETSTEM BIOPHARMA Company Information, Head Office, and Major Competitors
Table 6. VETSTEM BIOPHARMA Major Business
Table 7. VETSTEM BIOPHARMA Canine Stem Cell Therapy Product and Solutions
Table 8. VETSTEM BIOPHARMA Canine Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. VETSTEM BIOPHARMA Recent Developments and Future Plans
Table 10. Cell Therapy Sciences Company Information, Head Office, and Major Competitors
Table 11. Cell Therapy Sciences Major Business
Table 12. Cell Therapy Sciences Canine Stem Cell Therapy Product and Solutions
Table 13. Cell Therapy Sciences Canine Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Cell Therapy Sciences Recent Developments and Future Plans
Table 15. Regeneus Company Information, Head Office, and Major Competitors
Table 16. Regeneus Major Business
Table 17. Regeneus Canine Stem Cell Therapy Product and Solutions
Table 18. Regeneus Canine Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Regeneus Recent Developments and Future Plans
Table 20. Aratana Therapeutics Company Information, Head Office, and Major Competitors
Table 21. Aratana Therapeutics Major Business
Table 22. Aratana Therapeutics Canine Stem Cell Therapy Product and Solutions
Table 23. Aratana Therapeutics Canine Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Aratana Therapeutics Recent Developments and Future Plans
Table 25. Medivet Biologics Company Information, Head Office, and Major Competitors
Table 26. Medivet Biologics Major Business
Table 27. Medivet Biologics Canine Stem Cell Therapy Product and Solutions
Table 28. Medivet Biologics Canine Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Medivet Biologics Recent Developments and Future Plans
Table 30. Okyanos Company Information, Head Office, and Major Competitors
Table 31. Okyanos Major Business
Table 32. Okyanos Canine Stem Cell Therapy Product and Solutions
Table 33. Okyanos Canine Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Okyanos Recent Developments and Future Plans
Table 35. Vetbiologics Company Information, Head Office, and Major Competitors
Table 36. Vetbiologics Major Business
Table 37. Vetbiologics Canine Stem Cell Therapy Product and Solutions
Table 38. Vetbiologics Canine Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Vetbiologics Recent Developments and Future Plans
Table 40. VetMatrix Company Information, Head Office, and Major Competitors
Table 41. VetMatrix Major Business
Table 42. VetMatrix Canine Stem Cell Therapy Product and Solutions
Table 43. VetMatrix Canine Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. VetMatrix Recent Developments and Future Plans
Table 45. Magellan Stem Cells Company Information, Head Office, and Major Competitors
Table 46. Magellan Stem Cells Major Business
Table 47. Magellan Stem Cells Canine Stem Cell Therapy Product and Solutions
Table 48. Magellan Stem Cells Canine Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Magellan Stem Cells Recent Developments and Future Plans
Table 50. ANIMAL CELL THERAPIES Company Information, Head Office, and Major Competitors
Table 51. ANIMAL CELL THERAPIES Major Business
Table 52. ANIMAL CELL THERAPIES Canine Stem Cell Therapy Product and Solutions
Table 53. ANIMAL CELL THERAPIES Canine Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. ANIMAL CELL THERAPIES Recent Developments and Future Plans
Table 55. Stemcellvet Company Information, Head Office, and Major Competitors
Table 56. Stemcellvet Major Business
Table 57. Stemcellvet Canine Stem Cell Therapy Product and Solutions
Table 58. Stemcellvet Canine Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Stemcellvet Recent Developments and Future Plans
Table 60. Global Canine Stem Cell Therapy Revenue (USD Million) by Players (2018-2023)
Table 61. Global Canine Stem Cell Therapy Revenue Share by Players (2018-2023)
Table 62. Breakdown of Canine Stem Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 63. Market Position of Players in Canine Stem Cell Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 64. Head Office of Key Canine Stem Cell Therapy Players
Table 65. Canine Stem Cell Therapy Market: Company Product Type Footprint
Table 66. Canine Stem Cell Therapy Market: Company Product Application Footprint
Table 67. Canine Stem Cell Therapy New Market Entrants and Barriers to Market Entry
Table 68. Canine Stem Cell Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global Canine Stem Cell Therapy Consumption Value (USD Million) by Type (2018-2023)
Table 70. Global Canine Stem Cell Therapy Consumption Value Share by Type (2018-2023)
Table 71. Global Canine Stem Cell Therapy Consumption Value Forecast by Type (2024-2029)
Table 72. Global Canine Stem Cell Therapy Consumption Value by Application (2018-2023)
Table 73. Global Canine Stem Cell Therapy Consumption Value Forecast by Application (2024-2029)
Table 74. North America Canine Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 75. North America Canine Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 76. North America Canine Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 77. North America Canine Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 78. North America Canine Stem Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 79. North America Canine Stem Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 80. Europe Canine Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Europe Canine Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Europe Canine Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 83. Europe Canine Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 84. Europe Canine Stem Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe Canine Stem Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific Canine Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 87. Asia-Pacific Canine Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 88. Asia-Pacific Canine Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 89. Asia-Pacific Canine Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 90. Asia-Pacific Canine Stem Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 91. Asia-Pacific Canine Stem Cell Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 92. South America Canine Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 93. South America Canine Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 94. South America Canine Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 95. South America Canine Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 96. South America Canine Stem Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 97. South America Canine Stem Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Middle East & Africa Canine Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 99. Middle East & Africa Canine Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 100. Middle East & Africa Canine Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 101. Middle East & Africa Canine Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 102. Middle East & Africa Canine Stem Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 103. Middle East & Africa Canine Stem Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 104. Canine Stem Cell Therapy Raw Material
Table 105. Key Suppliers of Canine Stem Cell Therapy Raw Materials
List of Figures
Figure 1. Canine Stem Cell Therapy Picture
Figure 2. Global Canine Stem Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Canine Stem Cell Therapy Consumption Value Market Share by Type in 2022
Figure 4. Allogeneic Stem Cells
Figure 5. Autologous Stem cells
Figure 6. Global Canine Stem Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Canine Stem Cell Therapy Consumption Value Market Share by Application in 2022
Figure 8. Veterinary Hospitals Picture
Figure 9. Veterinary Clinics Picture
Figure 10. Veterinary Research Institutes Picture
Figure 11. Global Canine Stem Cell Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Canine Stem Cell Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Canine Stem Cell Therapy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Canine Stem Cell Therapy Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Canine Stem Cell Therapy Consumption Value Market Share by Region in 2022
Figure 16. North America Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Canine Stem Cell Therapy Revenue Share by Players in 2022
Figure 22. Canine Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Canine Stem Cell Therapy Market Share in 2022
Figure 24. Global Top 6 Players Canine Stem Cell Therapy Market Share in 2022
Figure 25. Global Canine Stem Cell Therapy Consumption Value Share by Type (2018-2023)
Figure 26. Global Canine Stem Cell Therapy Market Share Forecast by Type (2024-2029)
Figure 27. Global Canine Stem Cell Therapy Consumption Value Share by Application (2018-2023)
Figure 28. Global Canine Stem Cell Therapy Market Share Forecast by Application (2024-2029)
Figure 29. North America Canine Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Canine Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Canine Stem Cell Therapy Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Canine Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Canine Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Canine Stem Cell Therapy Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 39. France Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Canine Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Canine Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Canine Stem Cell Therapy Consumption Value Market Share by Region (2018-2029)
Figure 46. China Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 49. India Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Canine Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Canine Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Canine Stem Cell Therapy Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Canine Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Canine Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Canine Stem Cell Therapy Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 63. Canine Stem Cell Therapy Market Drivers
Figure 64. Canine Stem Cell Therapy Market Restraints
Figure 65. Canine Stem Cell Therapy Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Canine Stem Cell Therapy in 2022
Figure 68. Manufacturing Process Analysis of Canine Stem Cell Therapy
Figure 69. Canine Stem Cell Therapy Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

VETSTEM BIOPHARMA
Cell Therapy Sciences
Regeneus
Aratana Therapeutics
Medivet Biologics
Okyanos
Vetbiologics
VetMatrix
Magellan Stem Cells
ANIMAL CELL THERAPIES
Stemcellvet
btl

Related Reports

Global Canine Stem Cell Therapy Supply, Demand and Key Producers, 2023-2029 xian22

Global Canine Stem Cell Therapy Supply, Demand and Key Producers, 2023-2029

date 16 Feb 2023

date Medical Care

Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Canine Stem Cell Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Canine Stem Cell Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 103

Published Date: 07 Jan 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.

According to our (Global Info Research) latest study, the global Canine Stem Cell Therapy market size was valued at USD 63 million in 2022 and is forecast to a readjusted size of USD 80 million by 2029 with a CAGR of 3.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Market competition is intense. Medivet Biologics LLC, VETSTEM BIOPHARMA and J-ARM, etc. are the leaders of the industry, with about 52% market shares.

North America is the largest consumption region of animal stem cell therapy, with a consumption market share nearly 58%. Japan is the second largest supplier of animal stem cell therapy, enjoying production market share nearly 15%.

This report is a detailed and comprehensive analysis for global Canine Stem Cell Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Canine Stem Cell Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global Canine Stem Cell Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Canine Stem Cell Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Canine Stem Cell Therapy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Canine Stem Cell Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Canine Stem Cell Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include VETSTEM BIOPHARMA, Cell Therapy Sciences, Regeneus, Aratana Therapeutics and Medivet Biologics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Canine Stem Cell Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Allogeneic Stem Cells
Autologous Stem cells

Market segment by Application
Veterinary Hospitals
Veterinary Clinics
Veterinary Research Institutes

Market segment by players, this report covers
VETSTEM BIOPHARMA
Cell Therapy Sciences
Regeneus
Aratana Therapeutics
Medivet Biologics
Okyanos
Vetbiologics
VetMatrix
Magellan Stem Cells
ANIMAL CELL THERAPIES
Stemcellvet

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Canine Stem Cell Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Canine Stem Cell Therapy, with revenue, gross margin and global market share of Canine Stem Cell Therapy from 2018 to 2023.
Chapter 3, the Canine Stem Cell Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Canine Stem Cell Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Canine Stem Cell Therapy.
Chapter 13, to describe Canine Stem Cell Therapy research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Canine Stem Cell Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Canine Stem Cell Therapy by Type
1.3.1 Overview: Global Canine Stem Cell Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Canine Stem Cell Therapy Consumption Value Market Share by Type in 2022
1.3.3 Allogeneic Stem Cells
1.3.4 Autologous Stem cells
1.4 Global Canine Stem Cell Therapy Market by Application
1.4.1 Overview: Global Canine Stem Cell Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Veterinary Hospitals
1.4.3 Veterinary Clinics
1.4.4 Veterinary Research Institutes
1.5 Global Canine Stem Cell Therapy Market Size & Forecast
1.6 Global Canine Stem Cell Therapy Market Size and Forecast by Region
1.6.1 Global Canine Stem Cell Therapy Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Canine Stem Cell Therapy Market Size by Region, (2018-2029)
1.6.3 North America Canine Stem Cell Therapy Market Size and Prospect (2018-2029)
1.6.4 Europe Canine Stem Cell Therapy Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Canine Stem Cell Therapy Market Size and Prospect (2018-2029)
1.6.6 South America Canine Stem Cell Therapy Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Canine Stem Cell Therapy Market Size and Prospect (2018-2029)

2 Company Profiles
2.1 VETSTEM BIOPHARMA
2.1.1 VETSTEM BIOPHARMA Details
2.1.2 VETSTEM BIOPHARMA Major Business
2.1.3 VETSTEM BIOPHARMA Canine Stem Cell Therapy Product and Solutions
2.1.4 VETSTEM BIOPHARMA Canine Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 VETSTEM BIOPHARMA Recent Developments and Future Plans
2.2 Cell Therapy Sciences
2.2.1 Cell Therapy Sciences Details
2.2.2 Cell Therapy Sciences Major Business
2.2.3 Cell Therapy Sciences Canine Stem Cell Therapy Product and Solutions
2.2.4 Cell Therapy Sciences Canine Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Cell Therapy Sciences Recent Developments and Future Plans
2.3 Regeneus
2.3.1 Regeneus Details
2.3.2 Regeneus Major Business
2.3.3 Regeneus Canine Stem Cell Therapy Product and Solutions
2.3.4 Regeneus Canine Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Regeneus Recent Developments and Future Plans
2.4 Aratana Therapeutics
2.4.1 Aratana Therapeutics Details
2.4.2 Aratana Therapeutics Major Business
2.4.3 Aratana Therapeutics Canine Stem Cell Therapy Product and Solutions
2.4.4 Aratana Therapeutics Canine Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Aratana Therapeutics Recent Developments and Future Plans
2.5 Medivet Biologics
2.5.1 Medivet Biologics Details
2.5.2 Medivet Biologics Major Business
2.5.3 Medivet Biologics Canine Stem Cell Therapy Product and Solutions
2.5.4 Medivet Biologics Canine Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Medivet Biologics Recent Developments and Future Plans
2.6 Okyanos
2.6.1 Okyanos Details
2.6.2 Okyanos Major Business
2.6.3 Okyanos Canine Stem Cell Therapy Product and Solutions
2.6.4 Okyanos Canine Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Okyanos Recent Developments and Future Plans
2.7 Vetbiologics
2.7.1 Vetbiologics Details
2.7.2 Vetbiologics Major Business
2.7.3 Vetbiologics Canine Stem Cell Therapy Product and Solutions
2.7.4 Vetbiologics Canine Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Vetbiologics Recent Developments and Future Plans
2.8 VetMatrix
2.8.1 VetMatrix Details
2.8.2 VetMatrix Major Business
2.8.3 VetMatrix Canine Stem Cell Therapy Product and Solutions
2.8.4 VetMatrix Canine Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 VetMatrix Recent Developments and Future Plans
2.9 Magellan Stem Cells
2.9.1 Magellan Stem Cells Details
2.9.2 Magellan Stem Cells Major Business
2.9.3 Magellan Stem Cells Canine Stem Cell Therapy Product and Solutions
2.9.4 Magellan Stem Cells Canine Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Magellan Stem Cells Recent Developments and Future Plans
2.10 ANIMAL CELL THERAPIES
2.10.1 ANIMAL CELL THERAPIES Details
2.10.2 ANIMAL CELL THERAPIES Major Business
2.10.3 ANIMAL CELL THERAPIES Canine Stem Cell Therapy Product and Solutions
2.10.4 ANIMAL CELL THERAPIES Canine Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 ANIMAL CELL THERAPIES Recent Developments and Future Plans
2.11 Stemcellvet
2.11.1 Stemcellvet Details
2.11.2 Stemcellvet Major Business
2.11.3 Stemcellvet Canine Stem Cell Therapy Product and Solutions
2.11.4 Stemcellvet Canine Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Stemcellvet Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Canine Stem Cell Therapy Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Canine Stem Cell Therapy by Company Revenue
3.2.2 Top 3 Canine Stem Cell Therapy Players Market Share in 2022
3.2.3 Top 6 Canine Stem Cell Therapy Players Market Share in 2022
3.3 Canine Stem Cell Therapy Market: Overall Company Footprint Analysis
3.3.1 Canine Stem Cell Therapy Market: Region Footprint
3.3.2 Canine Stem Cell Therapy Market: Company Product Type Footprint
3.3.3 Canine Stem Cell Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
4.1 Global Canine Stem Cell Therapy Consumption Value and Market Share by Type (2018-2023)
4.2 Global Canine Stem Cell Therapy Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
5.1 Global Canine Stem Cell Therapy Consumption Value Market Share by Application (2018-2023)
5.2 Global Canine Stem Cell Therapy Market Forecast by Application (2024-2029)

6 North America
6.1 North America Canine Stem Cell Therapy Consumption Value by Type (2018-2029)
6.2 North America Canine Stem Cell Therapy Consumption Value by Application (2018-2029)
6.3 North America Canine Stem Cell Therapy Market Size by Country
6.3.1 North America Canine Stem Cell Therapy Consumption Value by Country (2018-2029)
6.3.2 United States Canine Stem Cell Therapy Market Size and Forecast (2018-2029)
6.3.3 Canada Canine Stem Cell Therapy Market Size and Forecast (2018-2029)
6.3.4 Mexico Canine Stem Cell Therapy Market Size and Forecast (2018-2029)

7 Europe
7.1 Europe Canine Stem Cell Therapy Consumption Value by Type (2018-2029)
7.2 Europe Canine Stem Cell Therapy Consumption Value by Application (2018-2029)
7.3 Europe Canine Stem Cell Therapy Market Size by Country
7.3.1 Europe Canine Stem Cell Therapy Consumption Value by Country (2018-2029)
7.3.2 Germany Canine Stem Cell Therapy Market Size and Forecast (2018-2029)
7.3.3 France Canine Stem Cell Therapy Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Canine Stem Cell Therapy Market Size and Forecast (2018-2029)
7.3.5 Russia Canine Stem Cell Therapy Market Size and Forecast (2018-2029)
7.3.6 Italy Canine Stem Cell Therapy Market Size and Forecast (2018-2029)

8 Asia-Pacific
8.1 Asia-Pacific Canine Stem Cell Therapy Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Canine Stem Cell Therapy Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Canine Stem Cell Therapy Market Size by Region
8.3.1 Asia-Pacific Canine Stem Cell Therapy Consumption Value by Region (2018-2029)
8.3.2 China Canine Stem Cell Therapy Market Size and Forecast (2018-2029)
8.3.3 Japan Canine Stem Cell Therapy Market Size and Forecast (2018-2029)
8.3.4 South Korea Canine Stem Cell Therapy Market Size and Forecast (2018-2029)
8.3.5 India Canine Stem Cell Therapy Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Canine Stem Cell Therapy Market Size and Forecast (2018-2029)
8.3.7 Australia Canine Stem Cell Therapy Market Size and Forecast (2018-2029)

9 South America
9.1 South America Canine Stem Cell Therapy Consumption Value by Type (2018-2029)
9.2 South America Canine Stem Cell Therapy Consumption Value by Application (2018-2029)
9.3 South America Canine Stem Cell Therapy Market Size by Country
9.3.1 South America Canine Stem Cell Therapy Consumption Value by Country (2018-2029)
9.3.2 Brazil Canine Stem Cell Therapy Market Size and Forecast (2018-2029)
9.3.3 Argentina Canine Stem Cell Therapy Market Size and Forecast (2018-2029)

10 Middle East & Africa
10.1 Middle East & Africa Canine Stem Cell Therapy Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Canine Stem Cell Therapy Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Canine Stem Cell Therapy Market Size by Country
10.3.1 Middle East & Africa Canine Stem Cell Therapy Consumption Value by Country (2018-2029)
10.3.2 Turkey Canine Stem Cell Therapy Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Canine Stem Cell Therapy Market Size and Forecast (2018-2029)
10.3.4 UAE Canine Stem Cell Therapy Market Size and Forecast (2018-2029)

11 Market Dynamics
11.1 Canine Stem Cell Therapy Market Drivers
11.2 Canine Stem Cell Therapy Market Restraints
11.3 Canine Stem Cell Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
12.1 Canine Stem Cell Therapy Industry Chain
12.2 Canine Stem Cell Therapy Upstream Analysis
12.3 Canine Stem Cell Therapy Midstream Analysis
12.4 Canine Stem Cell Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Canine Stem Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Canine Stem Cell Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Canine Stem Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Canine Stem Cell Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 5. VETSTEM BIOPHARMA Company Information, Head Office, and Major Competitors
Table 6. VETSTEM BIOPHARMA Major Business
Table 7. VETSTEM BIOPHARMA Canine Stem Cell Therapy Product and Solutions
Table 8. VETSTEM BIOPHARMA Canine Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. VETSTEM BIOPHARMA Recent Developments and Future Plans
Table 10. Cell Therapy Sciences Company Information, Head Office, and Major Competitors
Table 11. Cell Therapy Sciences Major Business
Table 12. Cell Therapy Sciences Canine Stem Cell Therapy Product and Solutions
Table 13. Cell Therapy Sciences Canine Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Cell Therapy Sciences Recent Developments and Future Plans
Table 15. Regeneus Company Information, Head Office, and Major Competitors
Table 16. Regeneus Major Business
Table 17. Regeneus Canine Stem Cell Therapy Product and Solutions
Table 18. Regeneus Canine Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Regeneus Recent Developments and Future Plans
Table 20. Aratana Therapeutics Company Information, Head Office, and Major Competitors
Table 21. Aratana Therapeutics Major Business
Table 22. Aratana Therapeutics Canine Stem Cell Therapy Product and Solutions
Table 23. Aratana Therapeutics Canine Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Aratana Therapeutics Recent Developments and Future Plans
Table 25. Medivet Biologics Company Information, Head Office, and Major Competitors
Table 26. Medivet Biologics Major Business
Table 27. Medivet Biologics Canine Stem Cell Therapy Product and Solutions
Table 28. Medivet Biologics Canine Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Medivet Biologics Recent Developments and Future Plans
Table 30. Okyanos Company Information, Head Office, and Major Competitors
Table 31. Okyanos Major Business
Table 32. Okyanos Canine Stem Cell Therapy Product and Solutions
Table 33. Okyanos Canine Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Okyanos Recent Developments and Future Plans
Table 35. Vetbiologics Company Information, Head Office, and Major Competitors
Table 36. Vetbiologics Major Business
Table 37. Vetbiologics Canine Stem Cell Therapy Product and Solutions
Table 38. Vetbiologics Canine Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Vetbiologics Recent Developments and Future Plans
Table 40. VetMatrix Company Information, Head Office, and Major Competitors
Table 41. VetMatrix Major Business
Table 42. VetMatrix Canine Stem Cell Therapy Product and Solutions
Table 43. VetMatrix Canine Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. VetMatrix Recent Developments and Future Plans
Table 45. Magellan Stem Cells Company Information, Head Office, and Major Competitors
Table 46. Magellan Stem Cells Major Business
Table 47. Magellan Stem Cells Canine Stem Cell Therapy Product and Solutions
Table 48. Magellan Stem Cells Canine Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Magellan Stem Cells Recent Developments and Future Plans
Table 50. ANIMAL CELL THERAPIES Company Information, Head Office, and Major Competitors
Table 51. ANIMAL CELL THERAPIES Major Business
Table 52. ANIMAL CELL THERAPIES Canine Stem Cell Therapy Product and Solutions
Table 53. ANIMAL CELL THERAPIES Canine Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. ANIMAL CELL THERAPIES Recent Developments and Future Plans
Table 55. Stemcellvet Company Information, Head Office, and Major Competitors
Table 56. Stemcellvet Major Business
Table 57. Stemcellvet Canine Stem Cell Therapy Product and Solutions
Table 58. Stemcellvet Canine Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Stemcellvet Recent Developments and Future Plans
Table 60. Global Canine Stem Cell Therapy Revenue (USD Million) by Players (2018-2023)
Table 61. Global Canine Stem Cell Therapy Revenue Share by Players (2018-2023)
Table 62. Breakdown of Canine Stem Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 63. Market Position of Players in Canine Stem Cell Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 64. Head Office of Key Canine Stem Cell Therapy Players
Table 65. Canine Stem Cell Therapy Market: Company Product Type Footprint
Table 66. Canine Stem Cell Therapy Market: Company Product Application Footprint
Table 67. Canine Stem Cell Therapy New Market Entrants and Barriers to Market Entry
Table 68. Canine Stem Cell Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global Canine Stem Cell Therapy Consumption Value (USD Million) by Type (2018-2023)
Table 70. Global Canine Stem Cell Therapy Consumption Value Share by Type (2018-2023)
Table 71. Global Canine Stem Cell Therapy Consumption Value Forecast by Type (2024-2029)
Table 72. Global Canine Stem Cell Therapy Consumption Value by Application (2018-2023)
Table 73. Global Canine Stem Cell Therapy Consumption Value Forecast by Application (2024-2029)
Table 74. North America Canine Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 75. North America Canine Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 76. North America Canine Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 77. North America Canine Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 78. North America Canine Stem Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 79. North America Canine Stem Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 80. Europe Canine Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Europe Canine Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Europe Canine Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 83. Europe Canine Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 84. Europe Canine Stem Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe Canine Stem Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific Canine Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 87. Asia-Pacific Canine Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 88. Asia-Pacific Canine Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 89. Asia-Pacific Canine Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 90. Asia-Pacific Canine Stem Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 91. Asia-Pacific Canine Stem Cell Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 92. South America Canine Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 93. South America Canine Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 94. South America Canine Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 95. South America Canine Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 96. South America Canine Stem Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 97. South America Canine Stem Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Middle East & Africa Canine Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 99. Middle East & Africa Canine Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 100. Middle East & Africa Canine Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 101. Middle East & Africa Canine Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 102. Middle East & Africa Canine Stem Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 103. Middle East & Africa Canine Stem Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 104. Canine Stem Cell Therapy Raw Material
Table 105. Key Suppliers of Canine Stem Cell Therapy Raw Materials
List of Figures
Figure 1. Canine Stem Cell Therapy Picture
Figure 2. Global Canine Stem Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Canine Stem Cell Therapy Consumption Value Market Share by Type in 2022
Figure 4. Allogeneic Stem Cells
Figure 5. Autologous Stem cells
Figure 6. Global Canine Stem Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Canine Stem Cell Therapy Consumption Value Market Share by Application in 2022
Figure 8. Veterinary Hospitals Picture
Figure 9. Veterinary Clinics Picture
Figure 10. Veterinary Research Institutes Picture
Figure 11. Global Canine Stem Cell Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Canine Stem Cell Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Canine Stem Cell Therapy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Canine Stem Cell Therapy Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Canine Stem Cell Therapy Consumption Value Market Share by Region in 2022
Figure 16. North America Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Canine Stem Cell Therapy Revenue Share by Players in 2022
Figure 22. Canine Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Canine Stem Cell Therapy Market Share in 2022
Figure 24. Global Top 6 Players Canine Stem Cell Therapy Market Share in 2022
Figure 25. Global Canine Stem Cell Therapy Consumption Value Share by Type (2018-2023)
Figure 26. Global Canine Stem Cell Therapy Market Share Forecast by Type (2024-2029)
Figure 27. Global Canine Stem Cell Therapy Consumption Value Share by Application (2018-2023)
Figure 28. Global Canine Stem Cell Therapy Market Share Forecast by Application (2024-2029)
Figure 29. North America Canine Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Canine Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Canine Stem Cell Therapy Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Canine Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Canine Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Canine Stem Cell Therapy Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 39. France Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Canine Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Canine Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Canine Stem Cell Therapy Consumption Value Market Share by Region (2018-2029)
Figure 46. China Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 49. India Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Canine Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Canine Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Canine Stem Cell Therapy Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Canine Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Canine Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Canine Stem Cell Therapy Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Canine Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 63. Canine Stem Cell Therapy Market Drivers
Figure 64. Canine Stem Cell Therapy Market Restraints
Figure 65. Canine Stem Cell Therapy Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Canine Stem Cell Therapy in 2022
Figure 68. Manufacturing Process Analysis of Canine Stem Cell Therapy
Figure 69. Canine Stem Cell Therapy Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

VETSTEM BIOPHARMA
Cell Therapy Sciences
Regeneus
Aratana Therapeutics
Medivet Biologics
Okyanos
Vetbiologics
VetMatrix
Magellan Stem Cells
ANIMAL CELL THERAPIES
Stemcellvet
btl

Related Reports

Global Canine Stem Cell Therapy Supply, Demand and Key Producers, 2023-2029 xian22
q3

Global Canine Stem Cell Therapy Supply, Demand and Key Producers, 2023-2029

industry 16 Feb 2023

industry Medical Care

Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.

jiaGou

Add To Cart

gouMai

Buy Now